{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:19:15Z","timestamp":1781885955338,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,11,12]],"date-time":"2011-11-12T00:00:00Z","timestamp":1321056000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s11064-011-0642-8","type":"journal-article","created":{"date-parts":[[2011,11,11]],"date-time":"2011-11-11T03:55:31Z","timestamp":1320983731000},"page":"557-562","source":"Crossref","is-referenced-by-count":17,"title":["Epicatechin Inhibits Human Plasma Lipid Peroxidation Caused by Haloperidol In Vitro"],"prefix":"10.1007","volume":"37","author":[{"given":"Anna","family":"Dietrich-Muszalska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Kontek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Olas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Rabe-Jab\u0142o\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,12]]},"reference":[{"key":"642_CR1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2131\/jts.34.77","volume":"34","author":"S Al-Bloushi","year":"2009","unstructured":"Al-Bloushi S, Safer AM, Afzal M (2009) Mousa SA: green tea modulates reserpine toxicity in animal models. J Toxicol Sci 34:77\u201387","journal-title":"J Toxicol Sci"},{"key":"642_CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/schbul\/15.1.81","volume":"15","author":"P Allebeck","year":"1989","unstructured":"Allebeck P (1989) Schizophrenia: a life-shortening illness. Schizophr Bull 15:81\u201389","journal-title":"Schizophr Bull"},{"key":"642_CR3","doi-asserted-by":"crossref","unstructured":"Al-Malki AL, Moselhy SS (2010) The protective effect of epicatechin against oxidative stress and nephrotoxicity in rats induced by cyclosporine. Hum Exp Toxicol (in press)","DOI":"10.1177\/0960327110369820"},{"key":"642_CR4","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.2174\/092986708785132979","volume":"15","author":"PV Babu","year":"2008","unstructured":"Babu PV, Liu D (2008) Green tea catechins and cardiovascular health: an update. Curr Med Chem 15:1840\u20131850","journal-title":"Curr Med Chem"},{"key":"642_CR5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.euroneuro.2003.09.001","volume":"14","author":"N Bergemann","year":"2004","unstructured":"Bergemann N, Kopitz J, Kress KR, Frick A (2004) Plasma amisulpride levels in schizophrenia or schizoaffective disorder. Eur Neuropsychopharmacol 14:245\u2013250","journal-title":"Eur Neuropsychopharmacol"},{"key":"642_CR6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2005.05.019","volume":"78","author":"HG Berstein","year":"2005","unstructured":"Berstein HG, Bogerts B, Keilhoff G (2005) The many faces of nitric oxide in schizophrenia. A review. Schizoph Res 78:69\u201386","journal-title":"Schizoph Res"},{"key":"642_CR7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000077368","volume":"49","author":"G Dakhale","year":"2004","unstructured":"Dakhale G, Khanzode S, Saoji A, Khobragade L, Turankar A (2004) Oxidative damage and schizophrenia: the potential benefit by atypical antipsychotics. Neuropsychobiology 49:205\u2013209","journal-title":"Neuropsychobiology"},{"key":"642_CR8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1440-1819.2010.02132.x","volume":"64","author":"A Dietrich-Muszalska","year":"2010","unstructured":"Dietrich-Muszalska A, Kontek B (2010) Lipid peroxidation in patients with schizophrenia. Psychiatry Clin Neurosci 64:469\u2013475","journal-title":"Psychiatry Clin Neurosci"},{"key":"642_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000202822","volume":"59","author":"A Dietrich-Muszalska","year":"2009","unstructured":"Dietrich-Muszalska A, Olas B, Glowacki R, Bald E (2009) Oxidative\/nitrative modifications of plasma proteins and thiols from patients with schizophrenia. Neuropsychobiology 59:1\u20137","journal-title":"Neuropsychobiology"},{"key":"642_CR10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/09537100500128872","volume":"16","author":"A Dietrich-Muszalska","year":"2005","unstructured":"Dietrich-Muszalska A, Olas B, Rabe-Jablonska J (2005) Oxidative stress in blood platelets from schizophrenic patients. Platelets 16:386\u2013391","journal-title":"Platelets"},{"key":"642_CR11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/15622970902718790","volume":"11","author":"A Dietrich-Muszalska","year":"2010","unstructured":"Dietrich-Muszalska A, Olas B (2010) Inhibitory effects of polyphenol compounds on lipid peroxidation caused by antipsychotics (haloperidol and amisulpride) in human plasma in vitro. World J Biol Psychiatry 11:276\u2013281","journal-title":"World J Biol Psychiatry"},{"key":"642_CR12","first-page":"1","volume":"14","author":"A Dietrich-Muszalska","year":"2007","unstructured":"Dietrich-Muszalska A, Olas B (2007) Isoprostanes as indicators of oxidative stress in schizophrenia. World J Biol Psychiatry 14:1\u20136","journal-title":"World J Biol Psychiatry"},{"key":"642_CR13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/09537100802641499","volume":"20","author":"A Dietrich-Muszalska","year":"2009","unstructured":"Dietrich-Muszalska A, Olas B (2009) Modifications of blood platelet proteins of patients with schizophrenia. Platelets 20:90\u201396","journal-title":"Platelets"},{"key":"642_CR14","first-page":"13","volume":"4","author":"A Dietrich-Muszalska","year":"2004","unstructured":"Dietrich-Muszalska A, Rabe-Jablonska J, Zgirski A (2004) The effects of olanzapine (Zolafren) on lipid peroxidation in human blood platelets and plasma: in vitro studies. Psychiatria i Psychologia Kliniczna 4:13\u201319","journal-title":"Psychiatria i Psychologia Kliniczna"},{"key":"642_CR15","first-page":"215","volume":"4","author":"A Dietrich-Muszalska","year":"2004","unstructured":"Dietrich-Muszalska A (2004) Evaluation of the effects of different concentrations of risperidone, corresponding to the drug doses used in treatment of schizophrenic patients, on lipid peroxidation in plasma and blood platelets at in vitro studies. Psychiatria i Psychologia Kliniczna 4:215\u2013223","journal-title":"Psychiatria i Psychologia Kliniczna"},{"key":"642_CR16","first-page":"18","volume":"1","author":"A Dietrich-Muszalska","year":"2005","unstructured":"Dietrich-Muszalska A (2005) The impact of different concentrations of clozapine on changes of lipid peroxidation in human plasma\u2014in vitro studies. Psychiatria i Psychologia Kliniczna 1:18\u201325","journal-title":"Psychiatria i Psychologia Kliniczna"},{"key":"642_CR17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.schres.2003.11.001","volume":"70","author":"M Eerdekens","year":"2004","unstructured":"Eerdekens M, van Hove I, Remmerie B, Mannaert E (2004) Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia. Schizophr Res 70:91\u2013100","journal-title":"Schizophr Res"},{"key":"642_CR18","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/BF01938881","volume":"52","author":"ES Fiala","year":"1996","unstructured":"Fiala ES, Sodum RS, Bhattacharaya M, Li H (1996) (\u2212)-Epigallocatechin gallate, a polyphenolic tea antioxidant, inhibits peroxynitrite-mediated formation of 8-oxodeoxyguanosine and 3-nitrotyrosine. Experientia 52:922\u2013926","journal-title":"Experientia"},{"key":"642_CR19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.pnpbp.2005.11.009","volume":"30","author":"CS Gama","year":"2006","unstructured":"Gama CS, Salvador M, Andreazza AC, Kapczinski F, Silva Belmote-De-Abreu P (2006) Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia; a study of patients treated with a haloperidol or clozapine. Prog Neuropsychopharmacol Biol Psychiatry 30:512\u2013515","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"642_CR20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0006-2952(94)00424-K","volume":"49","author":"I Jeding","year":"1995","unstructured":"Jeding I, Evans PJ, Akanmu D, Dexter D, Spencer JD, Arunoma OI, Jenner P, Halliwell B (1995) Characterization of the potential antioxidants and pro-oxidant actions of some neuroleptic drugs. Biochem Pharmacol 49:359\u2013365","journal-title":"Biochem Pharmacol"},{"key":"642_CR21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1176\/appi.neuropsych.17.2.227","volume":"17","author":"S Kropp","year":"2005","unstructured":"Kropp S, Kern V, Lange K, Degner D, Hajak G, Kornhuber J, Ruther E, Emrich HM, Schneider U, Bleich S (2005) Oxidative stress during treatment with first- and second-generation antipsychotics. J Neuropsych 17:227\u2013231","journal-title":"J Neuropsych"},{"key":"642_CR22","first-page":"981","volume":"12","author":"HC Li","year":"2006","unstructured":"Li HC, Chen QZ, Ma Y, Zhou JF (2006) Imbalanced free radicals and antioxidant defense systems in schizophrenia: a comparative study. J Zhejian Univ Sci B 12:981\u2013986","journal-title":"J Zhejian Univ Sci B"},{"key":"642_CR23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/0006-3223(90)90490-S","volume":"28","author":"JB Lohr","year":"1990","unstructured":"Lohr JB, Kuczenski R, Bracha HS, Moir M, Jeste DV (1990) Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia. Biol Psychiatry 28:535\u2013539","journal-title":"Biol Psychiatry"},{"key":"642_CR24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jpsychires.2005.10.003","volume":"41","author":"MJ M\u00fcller","year":"2007","unstructured":"M\u00fcller MJ, Regenbogen B, H\u00e4rtter S, Eich FX, Hiemke Ch (2007) Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia. J Psychiatr Res 41:673\u2013679","journal-title":"J Psychiatr Res"},{"key":"642_CR25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1080\/01635580903532424","volume":"62","author":"RG Nath","year":"2010","unstructured":"Nath RG, Wu MY, Emami A, Chung FL (2010) Effects of epigallocatechin gallate, L-ascorbic acid, alpha-tocopherol, and dihydrolipoic acid on the formation of deoxyguanosine adducts derived from lipid peroxidation. Nutr Cancer 62:622\u2013699","journal-title":"Nutr Cancer"},{"key":"642_CR26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1006\/bbrc.1997.6254","volume":"232","author":"AS Pannala","year":"1997","unstructured":"Pannala AS, Rice-Evans CA, Halliwell B, Singh S (1997) Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. Biochem Biophys Res Commun 232:164\u2013168","journal-title":"Biochem Biophys Res Commun"},{"key":"642_CR27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3956(02)00048-1","volume":"37","author":"V Parikh","year":"2003","unstructured":"Parikh V, Khan MM, Mahadik SP (2003) Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J Psychiatr Res 37:43\u201351","journal-title":"J Psychiatr Res"},{"key":"642_CR28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0952-3278(96)90143-X","volume":"55","author":"RD Reddy","year":"1996","unstructured":"Reddy RD, Yao JK (1996) Free radical pathology in schizophrenia: a review. Prostaglandins Leukot Essent Fatty Acids 55:33\u201334","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"642_CR29","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1046\/j.1471-4159.1998.71031002.x","volume":"71","author":"Y Sagara","year":"1998","unstructured":"Sagara Y (1998) Induction of reactive oxygen species in neurons by haloperidol. J Neurochem 71:1002\u20131012","journal-title":"J Neurochem"},{"key":"642_CR30","doi-asserted-by":"crossref","first-page":"20735","DOI":"10.1093\/jn\/130.8.2073S","volume":"130","author":"A Scalbert","year":"2000","unstructured":"Scalbert A, Williamson G (2000) Dietary intake and bioavailability of polyphenols. J Nutr 130:20735\u201320855","journal-title":"J Nutr"},{"key":"642_CR31","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1006\/bbrc.2001.6134","volume":"289","author":"P Schroeder","year":"2001","unstructured":"Schroeder P, Zhang H, Klotz LO, Kalyanaraman B, Sies H (2001) (\u2212)-Epicatechin inhibits nitration and dimerization of tyrosine in hydrophilic as well as hydrophobic environments. Biochem Biophys Res Commun 289:1334\u20131338","journal-title":"Biochem Biophys Res Commun"},{"key":"642_CR32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/BF02980053","volume":"27","author":"IW Seol","year":"2004","unstructured":"Seol IW, Kuo NY, Kim KM (2004) Effects of dopaminergic drugs on the mast cell degarulation and nitrix oxide generation in RAW 264.7 cells. Arch Pharm Res 27:94\u201398","journal-title":"Arch Pharm Res"},{"key":"642_CR33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s002130100860","volume":"158","author":"N Srivastava","year":"2001","unstructured":"Srivastava N, Barthwal MK, Dalal PK, Agarwal AK, Nag D, Srimal RC, Seth PK, Dikshit M (2001) Nitrite content and antioxidant enzymes levels in the blood of schizophrenic patients. Psychopharmacology 158:140\u2013145","journal-title":"Psychopharmacology"},{"key":"642_CR34","doi-asserted-by":"crossref","unstructured":"Taylor D, Paton C, Kerwin R (2003) The south London and maudsley NHS trust. Prescribing guidelines, 7th edn. Martin Dunitz, Taylor and Francis Group. London and New York","DOI":"10.3109\/9780203414125"},{"key":"642_CR35","first-page":"44084","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. IJBCB 39:44084","journal-title":"IJBCB"},{"key":"642_CR36","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cbf.290020310","volume":"2","author":"B Wachowicz","year":"1984","unstructured":"Wachowicz B (1984) Adenine nucleotides in thrombocytes of birds. Cell Biochem Funct 2:167\u2013170","journal-title":"Cell Biochem Funct"},{"key":"642_CR37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2165\/00023210-200115040-00004","volume":"15","author":"JK Yao","year":"2001","unstructured":"Yao JK, Reddy R, Mcelhinny LG, Van Kammen DP (2001) Oxidative damage and schizphrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 15:287\u2013310","journal-title":"CNS Drugs"},{"key":"642_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(98)00030-9","volume":"32","author":"JK Yao","year":"1998","unstructured":"Yao JK, Reddy R, Mcelhinny LG, Van Kammen DP (1998) Reduced status of plasma total antioxidant capacity in schizophrenia. Schizoph Res 32:1\u20138","journal-title":"Schizoph Res"},{"key":"642_CR39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.plefa.2006.11.003","volume":"76","author":"J Young","year":"2007","unstructured":"Young J, Mckinney SB, Ross BM, Wahle KW, Boyle SP (2007) Biomarkers of oxidative stress in schizophrenic and control subjects. Prostaglandins Leukot Essent Fatty Acids 76:73\u201385","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"642_CR40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.schres.2005.10.011","volume":"81","author":"XY Zhang","year":"2006","unstructured":"Zhang XY, Tan YL, Cao LY, Wu GY, Xu Q, Shen Y, Zhou DF (2006) Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophr Res 81:291\u2013300","journal-title":"Schizophr Res"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-011-0642-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-011-0642-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-011-0642-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T10:51:14Z","timestamp":1593255074000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-011-0642-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,12]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["642"],"URL":"https:\/\/doi.org\/10.1007\/s11064-011-0642-8","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,12]]}}}